Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood–brain barrier, beta amyloid, and tau proteins in people living with HIV

Abstract Among 128 adult people living with HIV and no neurological conditions confounding the cerebrospinal fluid results, the presence of HSV-1 chronic infection (detected either by serology or PCR), but not of HSV-2 and VZV, independently associated with higher odds of blood–brain barrier impairment, abnormally increased cerebrospinal fluid levels of tau and phosphorylated-181 tau, and decreased concentrations of fragments 1–42 of beta amyloid compared to the seronegative counterpart. These associations were even stronger for seropositive participants with a positive history of at least one symptomatic reactivation of HSV-1..

Medienart:

Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Journal of neurovirology - 29(2022), 1 vom: 09. Nov., Seite 100-105

Sprache:

Englisch

Beteiligte Personen:

Trunfio, Mattia [VerfasserIn]
Di Girolamo, Laura [VerfasserIn]
Ponzetta, Laura [VerfasserIn]
Russo, Marco [VerfasserIn]
Burdino, Elisa [VerfasserIn]
Imperiale, Daniele [VerfasserIn]
Atzori, Cristiana [VerfasserIn]
Di Perri, Giovanni [VerfasserIn]
Calcagno, Andrea [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Alzheimer’s dementia
Blood–brain barrier
Cerebrospinal fluid biomarkers
HIV
Herpes simplex
Varicella zoster

Anmerkungen:

© Journal of NeuroVirology, Inc. 2022

doi:

10.1007/s13365-022-01105-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2134400196